3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
7
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Leukemia
3
Hodgkin Disease
3
Melanoma
2
Immunoglobulin Light-chain Amyloidosis
2
Hematologic Neoplasms
2
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Interventions
Doxorubicin
33
Ifosfamide
23
Gemcitabine
19
pazopanib
18
Cyclophosphamide
16
Radiotherapy
15
pembrolizumab
13
Filgrastim
12
Docetaxel
12
Bevacizumab
10
Vincristine
9
Sirolimus
9
Irinotecan
9
Etoposide
9
olaratumab
7
eribulin
7
Sorafenib
7
Radiation
7
temsirolimus
6
Temozolomide
6
Mesna
6
Magnetic Resonance Spectroscopy
6
Cisplatin
6
tazemetostat
5
cixutumumab
5
Trabectedin
5
Radiosurgery
5
Nivolumab
5
Ipilimumab
5
Granulocyte Colony-Stimulating Factor
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma
×
Blood Component Removal
×
Clear all
No trials found.